A research team at the University of Adelaide, Australia has found a way to reduce brain swelling, the most common cause of death after stroke.
Studies by doctoral student Renée Turner in the Discipline of Pathology at the University of Adelaide have shown that swelling in the brain seems to mimic a similar process in the skin, and may well be amenable to treatment with drugs, although these are yet to be developed.
Advertisement
"This potentially provides the first new clinical pathway to reducing brain swelling in 50 years," Ms Turner says. "It should improve the chances of survival after a stroke and reduce the risk of long-term disabilities."
About 48,000 episodes of stroke occur in Australia each year, one every 11 minutes.
Brain swelling or oedema is a common complication of stroke. It occurs when water accumulates in the brain, causing compression and eventually death of brain tissue. The mechanism in the brain is unclear. But in the skin, a similar process known as neurogenic inflammation is triggered by nerve cells. This results in increased leakiness of blood vessels and water accumulation in the skin tissue.
A compound known as substance P has been shown to contribute to this swelling in the skin, Ms Turner says. Blocking substance P reduces skin tissue oedema.
"Until recently, neurogenic inflammation was not known to occur in the brain following injury. Our laboratory has now shown that substance P is released during stroke. And blocking substance P receptors following stroke subsequently reduces brain swelling and improves outcome and survival in rats."
(Source: Newswise)
Brain swelling or oedema is a common complication of stroke. It occurs when water accumulates in the brain, causing compression and eventually death of brain tissue. The mechanism in the brain is unclear. But in the skin, a similar process known as neurogenic inflammation is triggered by nerve cells. This results in increased leakiness of blood vessels and water accumulation in the skin tissue.
Advertisement
A compound known as substance P has been shown to contribute to this swelling in the skin, Ms Turner says. Blocking substance P reduces skin tissue oedema.
"Until recently, neurogenic inflammation was not known to occur in the brain following injury. Our laboratory has now shown that substance P is released during stroke. And blocking substance P receptors following stroke subsequently reduces brain swelling and improves outcome and survival in rats."
(Source: Newswise)
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Research News
New study sheds light on the intrinsic, yet often overlooked, role of sleep preparation as a hardwired survival strategy.
Microgravity-induced bone loss in space, can be reduced by systemic delivery of NELL-1, a protein required for bone growth and its maintenance.
Researchers establish connections between Alzheimer's-linked genetic alterations and the functioning of brain cells.
Team at NeuroRestore introduces a groundbreaking gene therapy that has effectively promoted nerve regrowth and reconnection, post spinal cord injury.
Scientists aim to pinpoint particular functional pathways affected by these bacteria that may have an impact on skeletal health.
